Shilpa Pharma Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 10.00 Cr
- Company Age 4 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1,150.50 Cr
- Satisfied Charges ₹ 73.00 Cr
- Revenue Growth %
- Profit Growth -1229.81%
- Ebitda 86.99%
- Net Worth 10.40%
- Total Assets 18.18%
About Shilpa Pharma Lifesciences
Shilpa Pharma Lifesciences Limited (SPLL) is a Public Limited Indian Non-Government Company incorporated in India on 08 May 2020 (Four years and nine months 17 days old ). Its registered office is in Raichur, Karnataka, India.
The Corporate was formerly known as Shilpa Corporate Holdings Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 10.00 Cr.
The company currently has active open charges totaling ₹1,150.50 Cr. The company has closed loans amounting to ₹73.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Shilpa Pharma Lifesciences Limited India are Alpesh Dalal as Cfo, Reetu Sharma as Company Secretary, and Santosh Mahil as Ceo. Vishnukanth Bhutada, Ramakant Innani, Kalakota Sharath, and Two other members serve as directors at the Company.
Company Details
- Location
Raichur, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100KA2020PLC134081
- Company No.
134081
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 May 2020
- Date of AGM
16 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Shilpa Pharma Lifesciences?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishnukanth Bhutada  | Managing Director | 08-May-2020 | Current |
| Alpesh Dalal | CFO | 12-Aug-2022 | Current |
| Reetu Sharma | Company Secretary | 12-Aug-2022 | Current |
| Santosh Mahil | CEO | 27-Apr-2024 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Keshav Bhutada | Director | 09-Mar-2022 | Current |
| Ramakant Innani | Director | 08-May-2020 | Current |
| Kalakota Sharath | Director | 29-Mar-2022 | Current |
| Anita Bandyopadhyay | Director | 12-Aug-2022 | Current |
Financial Performance of Shilpa Pharma Lifesciences.
Shilpa Pharma Lifesciences Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1229.81% decrease in profit. The company's net worth Soared by an impressive increase of 10.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shilpa Pharma Lifesciences?
In 2023, Shilpa Pharma Lifesciences had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vashi Integrated Solutions LimitedAnita Bandyopadhyay is a mutual person
Sravathi Ai Technology Private LimitedKeshav Bhutada is a mutual person
Sravathi Advance Process Technologies Private LimitedVishnukanth Bhutada and Ramakant Innani are mutual person
Inm Technologies Private LimitedVishnukanth Bhutada and Ramakant Innani are mutual person
Inm Nuvent Paints Private LimitedVishnukanth Bhutada and Ramakant Innani are mutual person
Ami Organics LimitedAnita Bandyopadhyay is a mutual person
Charges (Loans)
₹1,150.50 Cr
₹73.00 Cr
Charges Breakdown by Lending Institutions
- Others : 1000.50 Cr
- Axis Bank Limited : 150.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2024 | Others | ₹450.00 Cr | Open |
| 04 Aug 2023 | Others | ₹450.00 Cr | Open |
| 27 Feb 2023 | Others | ₹5.00 M | Open |
| 27 Oct 2022 | Axis Bank Limited | ₹150.00 Cr | Open |
| 19 Oct 2022 | Others | ₹100.00 Cr | Open |
How Many Employees Work at Shilpa Pharma Lifesciences?
Shilpa Pharma Lifesciences has a workforce of 1200 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shilpa Pharma Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shilpa Pharma Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
